SARS-CoV-2 spike does not interact with the T cell receptor or directly activate T cells.

Publication date: Jul 30, 2024

Suggested edit: SARS-CoV-2infection can induce multisystem inflammatory syndrome in children, which resembles superantigen-induced toxic shock syndrome. Recent work has suggested that the SARS-CoV-2 spike (S) protein could act as a superantigen by binding T cell receptors (TCRs) and inducing broad antigen-independent T cell responses. Structure-based computational modeling identified potential TCR-binding sites near the S receptor-binding domain, in addition to a site with homology to known neurotoxins. We experimentally examined the mechanism underpinning this theory-the direct interaction between the TCR and S protein. Surface plasmon resonance of recombinantly expressed S protein and TCR revealed no detectable binding. Orthogonally, we pseudotyped lentiviruses with SARS-CoV-2 S in both wild-type and prefusion-stabilized forms, demonstrated their functionality in a cell line assay, and observed no transduction, activation, or stimulation of proliferation of CD8 T cells. We conclude that it is unlikely that the SARS-CoV-2 spike protein engages nonspecifically with TCRs or has superantigenic character.

Concepts Keywords
Lentiviruses Binding Sites
Neurotoxins COVID-19
Protein HEK293 Cells
Recombinantly Humans
Spike Lymphocyte Activation
Protein Binding
Receptors, Antigen, T-Cell
Receptors, Antigen, T-Cell
SARS-CoV-2
SARS-CoV-2
Spike Glycoprotein, Coronavirus
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2
superantigen
T cell receptor
T-Lymphocytes

Semantics

Type Source Name
disease IDO cell
disease MESH multisystem inflammatory syndrome in children
disease MESH toxic shock syndrome
disease IDO site
disease IDO assay
disease MESH COVID-19
disease VO Glycoprotein

Original Article

(Visited 2 times, 1 visits today)